Drug Type Small molecule drug |
Synonyms RO 250993 |
Target |
Action inhibitors |
Mechanism Top II inhibitors(Topoisomerase II inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H31FKN4O9 |
InChIKeyAVLPXBWVJAKFOM-HQEYNUMISA-N |
CAS Registry141115-26-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | Switzerland | - | |
Bacterial Infections | Preclinical | - | - |